5JA1 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Sprint Bioscience AB

Watchlist Manager

Watchlist

Price: 0.309 EUR -1.9% Market Closed

Market Cap: €21.6m

	Sprint Bioscience AB F:5JA1	SE
	Titan Cement International SA F:TCJ	BE
	Merck KGaA F:MRKC	DE
L	Lumentum Holdings Inc XBER:LU2	US
C	China Coal Energy Co Ltd XHAM:CVV	CN
L	London Stock Exchange Group PLC XMUN:LS4C	UK
S	Shanghai Electric Group Co Ltd XBER:USR	CN
	Ameris Bancorp NYSE:ABCB	US
C	Conmed Corp F:EC8	US
B	Bradespar SA XBER:FXMA	BR

Profitability Summary

Sprint Bioscience AB's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

92%

Negative 3Y Average Gross Margin

-1.386%

Gross Margin is Increasing

-31.134% > 92%

Exceptional Operating Margin

58%

Negative 3Y Average Operating Margin

-7.813%

Operating Margin is Increasing

-154.361% > 58%

Exceptional Net Margin

55%

Negative 3Y Average Net Margin

-7.772%

Net Margin is Increasing

-153.287% > 55%

Exceptional Free Cash Flow Margin

50%

Negative 3Y Average Free Cash Flow Margin

-6.544%

Free Cash Flow Margin is Increasing

-125.371% > 50%

Exceptional ROE

143%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-120%

ROIC is Increasing

-1.282% > 1.140%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.